FDA Import Refusal AEK-7618056-9/20002/1 — TORRENT PHARMA LIMITED
The FDA refused shipment AEK-7618056-9/20002/1 from TORRENT PHARMA LIMITED (India) on Oct 14, 2025. The refused product falls under Drugs and Biologics — SERTRALINE HYDROCHLORIDE (ANTI-DEPRESSANT). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Oct 14, 2025
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61NDY78 SERTRALINE HYDROCHLORIDE (ANTI-DEPRESSANT)
- Charges
- 75